In this Issue:
Use of oncology medications: challenges & safe practices
Consensus guidelines for safe handling of MABs
NIOSH guidance for hazardous drugs
Biosimilars: how different is similar?
Dosing algorithms in oncology: does one size fit all?
Pharmacist prescribing in Canada
Medication safety with IT chemotherapy
Hepatoxicities of tyrosine kinase inhibitors
Oncolytic viruses as new cancer therapeutics
Global perspectives in oral antineoplastic agents
Please login below to download this issue (PDF)